Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV003103838 | SCV000885988 | uncertain significance | Bone fragility with contractures, arterial rupture, and deafness | 2022-03-02 | criteria provided, single submitter | clinical testing | The PLOD3 c.1466C>T; p.Pro489Leu variant is not reported in the medical literature, in the ClinVar database, or in gene-specific databases. The variant is listed in the dbSNP variant database (rs145508748), in the Exome Variant Server with an allele frequency of 0.0308 percent (4/13002 alleles), and in the Genome Aggregation Database with an allele frequency of 0.05161 percent (143/277082 alleles, 3 homozygotes). The proline at this position is conserved across species and computational algorithms (PolyPhen2, SIFT) predict this variant is deleterious. Considering available information, the clinical significance of this variant cannot be determined with certainty. |
Ce |
RCV000757677 | SCV000892794 | uncertain significance | not provided | 2018-04-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000757677 | SCV002402430 | benign | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Neurovascular Genetics Laboratory, |
RCV002273826 | SCV002558786 | uncertain significance | Hemorrhage, intracerebral, susceptibility to | 2022-08-05 | criteria provided, single submitter | research | |
Prevention |
RCV004547949 | SCV004737758 | likely benign | PLOD3-related disorder | 2023-07-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |